Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry.
about
The importance of mass spectrometric dereplication in fungal secondary metabolite analysisFragmentation trees reloadedIdentification of "known unknowns" utilizing accurate mass data and ChemSpiderIdentification of six new Alternaria sulfoconjugated metabolites by high-resolution neutral loss filteringAssessment of metabolome annotation quality: a method for evaluating the false discovery rate of elemental composition searchesBioinformatics: the next frontier of metabolomicsAdvances in structure elucidation of small molecules using mass spectrometryPrediction, Detection, and Validation of Isotope Clusters in Mass Spectrometry DataScreening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition.Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity.High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.Identification of volatile and semivolatile compounds in chemical ionization GC-MS using a mass-to-structure (MTS) Search Engine with integral isotope pattern ranking.Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.Bioanalysis of new designer drugs.Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition.Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography.Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.Identification of "known unknowns" utilizing accurate mass data and chemical abstracts service databases.Use of soft and hard ionization techniques for elucidation of unknown compounds by gas chromatography/time-of-flight mass spectrometry.Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasmaCombining targeted and nontargeted data analysis for liquid chromatography/high-resolution mass spectrometric analyses.True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data.First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.Developing a UHPLC-QTOF-MS and Automated Library Search Method for Screening Drugs and Toxic Compounds in Postmortem Specimens.Accurate determination of tissue steroid hormones, precursors and conjugates in adult male rat.Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimensComprehensive screening and quantification of veterinary drugs in milk using UPLC-ToF-MS.Laboratory diagnostics in acute poisoning: critical overview.Database searching for structural identification of metabolites in complex biofluids for mass spectrometry-based metabonomics.Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.The analysis of antipsychotic drugs in human matrices using LC-MS(/MS).Liquid chromatography tandem mass spectrometry in the clinical laboratory.The current state-of-the-art in the determination of pharmaceutical residues in environmental matrices using hyphenated techniques.Aggressive dereplication using UHPLC-DAD-QTOF: screening extracts for up to 3000 fungal secondary metabolites.Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology.
P2860
Q26865794-591C995F-05B6-4B5E-9C70-7C4E00C4732DQ27902332-60F8F56E-42DD-46BA-9F7D-E07D0426A1A5Q28252658-543D120F-7EFD-472C-863E-F62A26834510Q28266885-F17D34F1-3955-46FC-A306-FB4336560D33Q28476330-00A4DF44-AC4C-4D3A-B290-2CCB32801393Q28652509-FDBCED0B-FB06-45B3-9B7C-0524D594BEC4Q28743720-109F840B-521D-431C-8367-260890C5DEF8Q28818521-461CFD97-07BE-4FE9-B560-ACA2BABD9B17Q30619552-207E37BA-D594-4331-93D1-6B8968320D43Q33326392-E29EF2D5-5528-4393-9DE3-3A575C84C6CBQ33439410-4941CA64-75B1-4FBE-834B-762CFA934D82Q33456693-28D8B754-FBFB-4B2C-96A5-D2B1998A5E1CQ33739604-9EFFBD4D-C751-4178-8D47-B7BDCDBD0454Q33748885-5781245F-17C6-488B-AC79-D346A1697811Q33762355-7D07AF29-1F18-4ACC-8052-0DFF752A5EAEQ33776858-A0A571B5-F3E5-4793-A2BE-B6CB13861539Q33811853-5E794667-8F87-4474-B1B8-F10F6AE783FEQ33864845-A17B2A47-5E33-404F-8A04-487465818E0AQ33905549-5A7AAF3F-4705-4E3E-ACE6-7EFB212DD7CAQ34149545-59C7673D-B3A4-4FF6-A87D-270ADD58588BQ34364856-5E243148-AC5F-4DFA-A6D5-A401FEAC46FDQ34541313-03DAEABD-220F-4F98-85B1-1164B6E50C62Q34570572-F9B47E3E-2A46-4925-8FEC-3E990115A34CQ34573371-9050CAF6-92AB-426F-8E74-108CD7F92CD6Q35162970-CC982DA8-F936-4E27-A6EE-6D4866776D19Q35840290-CF3CE62D-3CF5-40D1-9D54-116B7EDDA5FBQ36066921-31572282-3376-4A24-8B7E-9DF21DD49631Q36088120-5CCA7890-F32D-4A55-8694-209187EA5CBCQ36332263-92299AC9-AC02-4FB1-B7ED-3CEA02A95F27Q36481977-B4B3BFA9-84C9-4E1A-9FF8-D42270F84E75Q36647089-55443918-1595-48C8-A779-DF117FF96980Q36739658-063D88A9-A259-4045-906B-2A06B846F5A9Q37775631-9C036BCC-6B57-4798-897D-5889877BA1E7Q37810165-EF5A7C55-14E1-4293-BAD2-0841F7969ECDQ37866806-7C963A97-F3C9-4D8A-8434-2418AB309F5DQ38008991-A9C7415D-0D21-4B9E-9F19-22BE3993B55AQ38260022-6BD1A9F4-3CF5-4E31-9C30-A65A8E89F9D8Q38267696-4F298709-95B2-4C38-8D55-DB299701E3C2Q38284217-ED669FAD-C7F3-4069-B75B-B4BA88E30D6DQ38423769-652E8626-6033-4ABB-A259-218AD63CF952
P2860
Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@ast
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@en
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@nl
type
label
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@ast
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@en
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@nl
prefLabel
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@ast
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@en
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@nl
P2093
P356
P1476
Isotopic pattern and accurate ...... e-of-flight mass spectrometry.
@en
P2093
Erkki Vuori
Ilmari Krebs
Matthias Pelzing
Suvi Ojanperä
P304
P356
10.1002/RCM.2429
P577
2006-01-01T00:00:00Z